{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:23:35Z","timestamp":1778815415469,"version":"3.51.4"},"reference-count":103,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Skin cancers (SC) collectively represent the most common type of malignancy in white populations. SC includes two main forms: malignant melanoma and non-melanoma skin cancer (NMSC). NMSC includes different subtypes, namely, basal cell carcinoma (BCC), squamous cell carcinoma (SCC), Merkel cell carcinoma (MCC), and keratoacanthoma (KA), together with the two pre-neoplastic conditions Bowen disease (BD) and actinic keratosis (AK). Both malignant melanoma and NMSC are showing an increasing incidence rate worldwide, thus representing an important challenge for health care systems, also because, with some exceptions, SC are generally characterized by an aggressive behavior and are often diagnosed late. Thus, identifying new biomarkers suitable for diagnosis, as well as for prognosis and targeted therapy is mandatory. Nicotinamide N-methyltransferase (NNMT) is an enzyme that is emerging as a crucial player in the progression of several malignancies, while its substrate, nicotinamide, is known to exert chemopreventive effects. Since there is increasing evidence regarding the involvement of this enzyme in the malignant behavior of SC, the current review aims to summarize the state of the art as concerns NNMT role in SC and to support future studies focused on exploring the diagnostic and prognostic potential of NNMT in skin malignancies and its suitability for targeted therapy.<\/jats:p>","DOI":"10.3390\/cancers13194943","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T10:55:40Z","timestamp":1633085740000},"page":"4943","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N-Methyltransferase as a Biomarker in Skin Cancers"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-2734","authenticated-orcid":false,"given":"Roberto","family":"Campagna","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Polytechnic University of Marche, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Pozzi","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Polytechnic University of Marche, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3879-8647","authenticated-orcid":false,"given":"Davide","family":"Sartini","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Polytechnic University of Marche, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2405-8947","authenticated-orcid":false,"given":"Eleonora","family":"Salvolini","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Polytechnic University of Marche, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3033-8024","authenticated-orcid":false,"given":"Valerio","family":"Brisigotti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Molinelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Campanati","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Offidani","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60100 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Emanuelli","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Polytechnic University of Marche, 60100 Ancona, Italy"},{"name":"New York-Marche Structural Biology Center (NY-MaSBiC), Polytechnic University of Marche, 60131 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-3-030-46227-7_6","article-title":"Epidemiology of Skin Cancer: Update 2019","volume":"1268","author":"Leiter","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7181\/acfs.2020.00024","article-title":"A retrospective study of changes in skin cancer characteristics over 11 years","volume":"21","author":"Park","year":"2020","journal-title":"Arch. Craniofacial Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-2077.94323","article-title":"Nonmelanoma skin cancer","volume":"5","author":"Samarasinghe","year":"2012","journal-title":"J. Cutan. Aesthet. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Isola, A.L., Eddy, K., and Chen, S. (2016). Biology, Therapy and Implications of Tumor Exosomes in the Progression of Melanoma. Cancers, 8.","DOI":"10.3390\/cancers8120110"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3322\/canjclin.50.4.215","article-title":"Malignant melanoma: Prevention, early detection, and treatment in the 21st century","volume":"50","author":"Rigel","year":"2000","journal-title":"CA Cancer J. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ward, W.H., and Farma, J.M. (2017). Epidemiology of Melanoma. Cutaneous Melanoma: Etiology and Therapy, Codon Publications.","DOI":"10.15586\/codon.cutaneousmelanoma.2017"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00006534-195908000-00023","article-title":"Studies on melanoma. II. Sex and survival in human melanoma","volume":"24","author":"White","year":"1959","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000216771.81362.6b","article-title":"Gender-Related Differences in Outcome for Melanoma Patients","volume":"243","author":"Scoggins","year":"2006","journal-title":"Ann. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(87)70230-8","article-title":"Number of melanocytic nevi as a major risk factor for ma-lignant melanoma","volume":"17","author":"Holly","year":"1987","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ijc.2910620403","article-title":"Risk of cutaneous melanoma associated with a family history of the disease","volume":"62","author":"Ford","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/bjc.1979.260","article-title":"Variation of melanoma incidence with latitude in North America and Europe","volume":"40","author":"Crombie","year":"1979","journal-title":"Br. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00105-012-2395-y","article-title":"Epidemiology of occupational skin cancer due to UV-irradiation","volume":"63","author":"Diepgen","year":"2012","journal-title":"Hautarzt"},{"key":"ref_16","first-page":"15","article-title":"The ABCDEF Rule: Combining the \u201cABCDE Rule\u201d and the \u201cUgly Duckling Sign\u201d in an Effort to Improve Patient Self-Screening Examinations","volume":"8","author":"Elewski","year":"2015","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA A Cancer J. Clin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00432-018-2726-1","article-title":"Melanoma treatment: From con-ventional to nanotechnology","volume":"144","author":"Mishra","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.annonc.2021.03.198","article-title":"Novel adjuvant options for cutaneous melanoma","volume":"32","author":"Dimitriou","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00008390-200410000-00013","article-title":"The role of taxanes in the treatment of metastatic melanoma","volume":"14","author":"Gogas","year":"2004","journal-title":"Melanoma Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jnci\/85.8.622","article-title":"Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer","volume":"85","author":"Rosenberg","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic mela-noma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Campagna, R., Bacchetti, T., Salvolini, E., Pozzi, V., Molinelli, E., Brisigotti, V., Sartini, D., Campanati, A., Ferretti, G., and Offidani, A. (2020). Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin. Antioxidants, 9.","DOI":"10.3390\/antiox9121238"},{"key":"ref_25","first-page":"1","article-title":"Proteomics in Melanoma Biomarker Discovery: Great Potential, Many Obstacles","volume":"2011","author":"Sabel","year":"2011","journal-title":"Int. J. Proteom."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"626129","DOI":"10.3389\/fonc.2020.626129","article-title":"Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities","volume":"10","author":"Eddy","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","article-title":"The epidemiology of skin cancer","volume":"146","author":"Diepgen","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13555-016-0165-y","article-title":"Skin Cancer: Epidemiology, Disease Burden, Patho-physiology, Diagnosis, and Therapeutic Approaches","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e13452","DOI":"10.1111\/eci.13452","article-title":"Paraoxonase-2: A potential biomarker for skin cancer aggressiveness","volume":"51","author":"Bacchetti","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Nikolouzakis, T.K., Falzone, L., Lasithiotakis, K., Kruger-Krasagakis, S., Kalogeraki, A., Sifaki, M., Spandidos, D.A., Chrysos, E., Tsatsakis, A., and Tsiaoussis, J. (2020). Current and Future Trends in Molecular Biomarkers for Diag-nostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092868"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/ced.14587","article-title":"Summary of the updated 2020 guidelines for cutaneous squamous cell carcinoma","volume":"46","author":"Woo","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cll.2017.06.003","article-title":"Cutaneous Squamous Cell Carcinoma","volume":"37","author":"Parekh","year":"2017","journal-title":"Clin. Lab. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"502723","DOI":"10.1155\/2011\/502723","article-title":"Cutaneous squamous cell carcinoma of the head and neck","volume":"2011","author":"Gurudutt","year":"2011","journal-title":"J. Skin Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sartini, D., Campagna, R., Lucarini, G., Pompei, V., Salvolini, E., Mattioli-Belmonte, M., Molinelli, E., Brisigotti, V., Campanati, A., and Bacchetti, T. (2021). Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma. Hum. Cell, 1\u20133.","DOI":"10.1007\/s13577-021-00581-5"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Paolino, G., Donati, M., Didona, D., Mercuri, S.R., and Cantisani, C. (2017). Histology of Non-Melanoma Skin Cancers: An Update. Biomedicines, 5.","DOI":"10.3390\/biomedicines5040071"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3747\/co.27.6015","article-title":"Multidisciplinary Management of Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma","volume":"27","author":"Claveau","year":"2020","journal-title":"Curr. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/DAD.0000000000001872","article-title":"Keratoacanthoma: Update on the Debate","volume":"43","author":"Nirenberg","year":"2020","journal-title":"Am. J. Dermatopathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.semdp.2009.09.003","article-title":"Keratoacanthoma: Hyperplasia, benign neoplasm, or a type of squamous cell carcinoma?","volume":"26","author":"Mandrell","year":"2009","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_39","first-page":"1","article-title":"Histopathological Variants of Cutaneous Squamous Cell Carcinoma: A Review","volume":"2011","author":"Yanofsky","year":"2010","journal-title":"J. Ski. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/jso.26319","article-title":"Immunotherapy for Merkel cell carcinoma","volume":"123","author":"Angeles","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/jso.25090","article-title":"Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients","volume":"117","author":"Verhoef","year":"2018","journal-title":"J. Surg. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3892\/or.2017.5700","article-title":"Low HtrA1 expression in patients with long-standing ulcerative colitis and colorectal cancer","volume":"38","author":"Altobelli","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Trager, M.H., Geskin, L.J., Samie, F.H., and Liu, L. (2020). Biomarkers in melanoma and non-melanoma skin cancer prevention and risk stratification. Exp. Dermatol.","DOI":"10.1111\/exd.14114"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"58642","DOI":"10.18632\/oncotarget.17407","article-title":"The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer","volume":"8","author":"Avellini","year":"2017","journal-title":"Oncotarget"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Galley, J.D., Mar, P., Wang, Y., Han, R., Rajab, A., and Besner, G.E. (2021). Urine-derived extracellular vesicle miRNAs as possible biomarkers for and mediators of necrotizing enterocolitis: A proof of concept study. J. Pediatr. Surg.","DOI":"10.1016\/j.jpedsurg.2021.02.016"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preghy.2019.08.005","article-title":"Association between first trimester plasma htra1 level and subsequent preeclampsia: A possible early marker?","volume":"18","author":"Gesuita","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"101072","DOI":"10.1016\/j.tranon.2021.101072","article-title":"The prognostic value of circulating tumor DNA in patients with melanoma: A systematic review and meta-analysis","volume":"14","author":"Feng","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/bjd.19750","article-title":"Cutaneous immune-related ad-verse events in patients with melanoma treated with checkpoint inhibitors","volume":"185","author":"Gault","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/ajd.12163","article-title":"Nicotinamide and the skin","volume":"55","author":"Chen","year":"2014","journal-title":"Australas. J. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2017.02.004","article-title":"Nicotinamide N -Methyltransferase: More Than a Vitamin B3 Clearance Enzyme","volume":"28","author":"Pissios","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMra0804615","article-title":"DNA damage, aging, and cancer","volume":"361","author":"Hoeijmakers","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Nikas, I.P., Paschou, S.A., and Ryu, H.S. (2020). The Role of Nicotinamide in Cancer Chemoprevention and Therapy. Biomolecules, 10.","DOI":"10.3390\/biom10030477"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1751-1097.2010.00746.x","article-title":"Nicotinamide prevents ultraviolet radiation-induced cellular energy loss","volume":"86","author":"Park","year":"2010","journal-title":"Photochem. Photobiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1039\/b9pp00146h","article-title":"Photoprotective effects of nicotinamide","volume":"9","author":"Damian","year":"2010","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Thompson, B.C., Halliday, G.M., and Damian, D.L. (2015). Nicotinamide enhances repair of arsenic and ultraviolet ra-diation-induced DNA damage in HaCaT keratinocytes and ex vivo human skin. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117491"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9958","DOI":"10.1128\/MCB.24.22.9958-9967.2004","article-title":"NAD + Modulates p53 DNA Binding Specificity and Function","volume":"24","author":"McLure","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"45099","DOI":"10.1074\/jbc.M205670200","article-title":"Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1","volume":"277","author":"Bitterman","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"119082","DOI":"10.1016\/j.bbamcr.2021.119082","article-title":"Nicotinamide N-methyltransferase in endothelium protects against oxidant stress-induced endothelial injury","volume":"1868","author":"Campagna","year":"2021","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1073\/pnas.94.10.5255","article-title":"The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers","volume":"94","author":"Vink","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/01635589709514618","article-title":"Prevention of photoimmunosuppression and photocarcinogenesis by topical nicotinamide","volume":"29","author":"Gensler","year":"1997","journal-title":"Nutr. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/carcin\/bgn248","article-title":"Oral nicotinamide protects against ul-traviolet radiation-induced immunosuppression in humans","volume":"30","author":"Yiasemides","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemo-prevention","volume":"373","author":"Chen","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/exd.12430","article-title":"Nicotinamide enhances repair of ultraviolet ra-diation-induced DNA damage in primary melanocytes","volume":"23","author":"Thompson","year":"2014","journal-title":"Exp. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1039\/c9pp00388f","article-title":"Nicotinamide for skin cancer chemoprevention: Effects of nicotinamide on melanoma in vitro and in vivo","volume":"19","author":"Malesu","year":"2020","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"14835","DOI":"10.1016\/S0021-9258(17)36700-5","article-title":"Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization","volume":"269","author":"Aksoy","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1021\/bi2007614","article-title":"Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase","volume":"50","author":"Peng","year":"2011","journal-title":"Biochemistry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"114019","DOI":"10.1016\/j.bcp.2020.114019","article-title":"Re-versal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotin-amide riboside","volume":"178","author":"Mateuszuk","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nchembio.1204","article-title":"NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink","volume":"9","author":"Ulanovskaya","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00784-018-2497-8","article-title":"Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: Effect on apoptosis and cell proliferation","volume":"23","author":"Seta","year":"2018","journal-title":"Clin. Oral Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1210\/jc.2002-021843","article-title":"Enhanced Expression of NicotinamideN-Methyltransferase in Human Papillary Thyroid Carcinoma Cells","volume":"88","author":"Xu","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1515\/hsz-2014-0231","article-title":"Role of nicotinamide N-methyltransferase in non-small cell lung cancer: In vitro effect of shRNA-mediated gene silencing on tumourigenicity","volume":"396","author":"Sartini","year":"2015","journal-title":"Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00432-009-0563-y","article-title":"Serum levels of nicotinamide N-methyltransferase in patients with lung cancer","volume":"135","author":"Tomida","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/emm.2006.54","article-title":"Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification","volume":"38","author":"Lim","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"ref_75","first-page":"649","article-title":"Nicotinamide N-methyltransferase: A potential biomarker for worse prognosis in gastric carcinoma","volume":"6","author":"Chen","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"580299","DOI":"10.3389\/fgene.2020.580299","article-title":"Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4161\/cbt.5.10.3323","article-title":"Differentiating pancreatic lesions by microarray and QPCR analysis of pan-creatic juice RNAs","volume":"5","author":"Rogers","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1159\/000369731","article-title":"Effects of nicotina-mide N-methyltransferase on PANC-1 cells proliferation, metastatic potential and survival under metabol-ic stress","volume":"35","author":"Yu","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1158\/1078-0432.CCR-05-0983","article-title":"Identification of nicotinamide N-methyltransferase as a novel serum tumor mark-er for colorectal cancer","volume":"11","author":"Roessler","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.14715\/cmb\/2018.64.7.9","article-title":"Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma","volume":"64","author":"Campagna","year":"2018","journal-title":"Cell. Mol. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/carcin\/bgq225","article-title":"Nicotinamide N -methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells","volume":"32","author":"Tang","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zhang, J., Wang, Y., Li, G., Yu, H., and Xie, X. (2014). Down-Regulation of Nicotinamide N-methyltransferase Induces Apoptosis in Human Breast Cancer Cells via the Mitochondria-Mediated Pathway. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089202"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5301\/ijbm.5000311","article-title":"Clinical performance and utility of a NNMT-based urine test for bladder cancer","volume":"33","author":"Pozzi","year":"2017","journal-title":"Int. J. Biol. Markers"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0002-9440(10)63605-X","article-title":"Expression profiling in ovarian clear cell carcinoma: Identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma","volume":"163","author":"Tsuchiya","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/iub.2265","article-title":"Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression","volume":"72","author":"Pozzi","year":"2020","journal-title":"IUBMB Life"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.juro.2006.07.046","article-title":"Identification of Nicotinamide N-Methyltransferase as a Novel Tumor Marker for Renal Clear Cell Carcinoma","volume":"176","author":"Sartini","year":"2006","journal-title":"J. Urol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2119\/2007-00035.Sartini","article-title":"Nicotinamide N-Methyltransferase Upregulation Inversely Correlates with Lymph Node Metastasis in Oral Squamous Cell Carcinoma","volume":"13","author":"Sartini","year":"2007","journal-title":"Mol. Med."},{"key":"ref_88","unstructured":"Emanuelli, M., Santarelli, A., Sartini, D., Ciavarella, M., Rossi, V., Pozzi, V., Rubini, C., and Muzio, L.L. (2010). Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma. Histol. Histopathol., 25."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/hsz-2012-0112","article-title":"Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: Basis for the development of a noninvasive diagnostic test for early-stage disease","volume":"393","author":"Sartini","year":"2012","journal-title":"Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/CMR.0000000000000430","article-title":"Nicotinamide N-methyltransferase: Potential involvement in cutaneous malignant melanoma","volume":"28","author":"Ganzetti","year":"2018","journal-title":"Melanoma Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/CMR.0000000000000548","article-title":"Analysis of nicotinamide N-methyltransferase in oral malignant melanoma and potential prognostic significance","volume":"29","author":"Mascitti","year":"2019","journal-title":"Melanoma Res."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Campagna, R., Salvolini, E., Pompei, V., Pozzi, V., Salvucci, A., Molinelli, E., Brisigotti, V., Sartini, D., Campanati, A., and Offidani, A. (2021). Nicotinamide N-methyltransferase gene silencing enhances chemosensi-tivity of melanoma cell lines. Pigment Cell Melanoma Res.","DOI":"10.1111\/pcmr.12993"},{"key":"ref_93","first-page":"1805","article-title":"Nicotinamide N-methyltransferase induces the proliferation and invasion of squamous cell carcinoma cells","volume":"42","author":"Hah","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e13175","DOI":"10.1111\/eci.13175","article-title":"Nicotinamide N-methyltransferase in nonmelanoma skin cancers","volume":"49","author":"Pompei","year":"2019","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_95","first-page":"e121","article-title":"Differential expression of nicotinamide N-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: An immunohistochemical study","volume":"34","author":"Sartini","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ijc.10631","article-title":"A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer","volume":"101","author":"Kassem","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.radonc.2011.05.086","article-title":"Cancer stem cell overex-pression of nicotinamide N-methyltransferase enhances cellular radiation resistance","volume":"99","author":"Safwat","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1021\/acs.jmedchem.7b00389","article-title":"Structure\u2013Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase","volume":"60","author":"Neelakantan","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1021\/acs.jmedchem.9b00413","article-title":"Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT) with Enhanced Activity","volume":"62","author":"Gao","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1038\/s41598-018-22081-7","article-title":"A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders","volume":"8","author":"Kannt","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"9837","DOI":"10.1021\/acs.jmedchem.9b01238","article-title":"High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT)","volume":"62","author":"Policarpo","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bmcl.2018.01.058","article-title":"Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase","volume":"28","author":"Ruf","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.bmcl.2018.04.017","article-title":"Covalent inhibi-tors of nicotinamide N-methyltransferase (NNMT) provide evidence for target engagement challenges in situ","volume":"28","author":"Lee","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/19\/4943\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:08:16Z","timestamp":1760166496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/19\/4943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":103,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["cancers13194943"],"URL":"https:\/\/doi.org\/10.3390\/cancers13194943","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]}}}